Akache, B., Renner, T. M., Tran, A., Deschatelets, L., Dudani, R., Harrison, B. A., . . . McCluskie, M. J. (2021). Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant. Nature Portfolio.
Cita Chicago Style (17a ed.)Akache, Bassel, et al. Immunogenic and Efficacious SARS-CoV-2 Vaccine Based on Resistin-trimerized Spike Antigen SmT1 and SLA Archaeosome Adjuvant. Nature Portfolio, 2021.
Cita MLA (8a ed.)Akache, Bassel, et al. Immunogenic and Efficacious SARS-CoV-2 Vaccine Based on Resistin-trimerized Spike Antigen SmT1 and SLA Archaeosome Adjuvant. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.